Julia Cartwright examines what Ozempic actually is — a diabetes medication, not an FDA-approved weight-loss drug — and explores the real experiences behind the headlines. We discuss effectiveness ranges, common side effects like nausea and gastroparesis, weight regain after stopping, and why semaglutide works best as one tool in comprehensive care.

Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Inception Point Ai. Innehållet i podden är skapat av Inception Point Ai och inte av, eller tillsammans med, Poddtoppen.